Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Learn why financial indices are useful benchmarks, guide portfolio decisions, and help you compare performance across assets.
25,072 articlesAxsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
A new survey shows almost 4 in 10 millennials take secret vacations while appearing online, forcing firms to rethink ...
With SpaceX poised to hit the public markets, a wave of megadeals led by Elon Musk looms. Analysts warn the IPO could...
A GMAC survey finds AI is replacing entry-level roles for about one-third of employers, with tech and manufacturing t...
Berkshire Hathaway’s surprise Alphabet investment signals a bold, long-term bet from Buffett. Learn the reasoning, ri...
A security flaw allowed access to thousands of connected robot vacuums across 24 countries, dragging AI home privacy ...
Brera stock is in sharp focus as the company leans into a crypto-first strategy connected to Solana. The move has spa...
You don't need a big windfall to start investing for the long term. With $100, you can assemble a simple, durable Van...
Legendary investor Paul Tudor Jones warns that the Trump-era market boom could end in a 30-35% correction, even as he...
NVDL plunged sharply in early 2025 as daily rebalancing magnified losses, even as NVDA fell less. Analysts warn this ...
medicare advantage’s premium comes with a catch that could affect coverage during serious illness. As enrollment tren...
Keel Infrastructure surged as it secured a large convertible financing to fuel AI data centers. This article breaks d...